Report Categories
View AllRecent Articles
View All
The opportunity most miss about Pharming PHAR Dives 20260508
MGRD Affiliated notches 62 percent Q4 2025 EPS beat shares slip 047 percent in todays regular trading
What General GPACU is doing that smarter investors notice Q4 2025 Better Than Expected
What Navigator NVGS flagged as biggest challenges ahead Navigator posts 339 EPS miss vs analyst estimates
Indias Gen Z Cockroach Movement Gains Momentum as Website Goes Offline
MalaysiaJapan Hydrogen Project Faces ScaleBack Amid Funding Constraints
Treasury Yields Dip Slightly as Iran Peace Deal Optimism Tempers Market Sentiment
US Payrolls Surge Above Expectations Yet Underlying Concerns Emerge
SpaceX Successfully Launches Starship on Second Attempt Strengthening Its Position in Private Spaceflight
China Emerges as Primary Rival in Humanoid Robot Arms Race Musk Warns
OSS Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally
Safe Pro Group Inc SPAI Q1 2026 Earnings WiderthanExpected Loss Reflects Investment Phase
ASR Q1 2026 Earnings EPS Misses Estimates by 153 Stock Declines
BCAX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
DXC Q1 2026 Earnings EPS Surpasses Estimates as Cost Actions Drive Profitability
ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
Skye Bioscience Surges 77 Biotech Stock Tests Resistance at 081
Andersen Group Inc ANDG Surges on Strong Volume Approaching Key Resistance
National Beverage Corp FIZZ Posts Modest Gain Amid Technical Consolidation
Marine Petroleum Trust MARPS Edges Lower Amid Light Trading
Lipocine Inc LPCN Edges Higher Amid Modest Uptick Technical Resistance in Sight